咨询热线

15000266580

当前位置:首页 >产品中心>细胞库>人正常细胞>CRL-1993HMy2.CIR 人B淋巴母细胞

HMy2.CIR 人B淋巴母细胞

简要描述:CRL-1993HMy2.CIR 人B淋巴母细胞,ATCC 细胞|细胞系|细胞株|肿瘤细胞|细胞|贴壁细胞|悬浮细胞|;细胞库管理规范,提供的细胞株背景清楚,提供参考文献和培养条件!

  • 产品型号:CRL-1993
  • 厂商性质:生产厂家
  • 更新时间:2021-07-13
  • 访  问  量:319

产品分类

Product Category

相关文章

Related Articles

详细介绍

CRL-1993HMy2.CIR 人B淋巴母细胞

ATCC® Number:CRL-1993™      
Designations:HMy2.CIR [C1R, HMy2.C1R]
Depositors: P Cresswell
Biosafety Level:2 [Cells contain Eptein-Barr Viral DNA sequences ]
Shipped:frozen
Medium & Serum:See Propagation
Growth Properties:suspension
Organism:Homo sapiens (human)
Morphology:lymphoblast
 
Source:Cell Type: B lymphoblast;
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
CRL-1993HMy2.CIR 人B淋巴母细胞
DNA Profile (STR):Amelogenin: X 
CSF1PO: 6,10 
D13S317: 11,13 
D16S539: 9,13 
D5S818: 10,13 
D7S820: 7,12 
THO1: 8 
TPOX: 8 
vWA: 17
Comments:The CRL-1621cell line is reported to be positive for Epstein-Barr nuclear antigen (EBNA +) and Epstein-Barr viral capsid antigen (EBVCA +). Since the HMy2.CIR cell line was derived from the HMy.2 B lymphoblastoid cell line, a fast growing mutant of the ARH-77 cell line (ATCC CRL-1621), it is assumed to be EBNA positive. 
The HMy2.CIR cell line was derived from the HMy.2 B lymphoblastoid cell line, a fast growing mutant of the ARH-77 cell line (ATCC CRL-1621), by gamma irradiation and selection for loss of HLA class I antigen expression. [23312] 
The cells express no HLA A or B locus products, but do express small amounts of HLA Cw4. 
The cells are useful as host for transfected class I major histocompatibility antigen genes.
Propagation:ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Iscove's Modified Dulbecco's Medium, Catalog No. 30-2005. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Atmosphere: air, 95%; carbon dioxide (CO2), 5% 
Temperature: 37.0°C
Subculturing:Protocol: Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10(5) viable cells/ml. 
Interval: Maintain between 2 X 10(5) and 1 X 10(6) viable cells/ml. 
Medium Renewal: Every 2 to 3 days
Preservation:Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO 
Storage temperature: liquid nitrogen vapor phase
Related Products:parental cell line:ATCC CRL-1621
derivative:ATCC CRL-2369
derivative:ATCC CRL-2370
derivative:ATCC CRL-2371
References:23312: Storkus WJ, et al. Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc. Natl. Acad. Sci. USA 86: 2361-2364, 1989. PubMed: 2784569

 

CRL-1993

产品咨询

留言框

  • 产品:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 省份:

  • 详细地址:

  • 补充说明:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7
联系方式

邮箱:xiangfbio@163.com

地址:上海市虹口区赤峰路630弄南雁大厦

咨询热线

400-821,8510

(周一至周日9:00- 19:00)

在线咨询
  • 扫一扫 微信咨询

Copyright©2021 上海复祥生物科技有限公司 All Right Reserved    备案号:沪ICP备10013034号-2     sitemap.xml
技术支持:化工仪器网    管理登陆